Clearside BioMedical Inc (CLSD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
28 Pages - GLDATA62710
$250.00

Summary

Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that provides development and commercialization of therapeutics. The company offers administration of active ingredients such as SCS injection of CLS-TA, SCS injection of CLS-TA and SCS injection of anti-VEGF compound or compound with dual anti-VEGF and anti-PDGF activity. Its products indicate macular edema associated with non- infectious uveitis, macular edema associated with retinal vein occlusion and wet age-related macular degeneration applications. The company also provides business development contract, license agreements and contract manufacturing services. It operates through its offices in Alpharetta and Durham, the US. Clearside is headquartered in Alpharetta, Georgia, the US.

Clearside BioMedical Inc (CLSD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Clearside BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Clearside Biomedical Raises USD0.3 Million in Venture Financing 12
Clearside Biomedical Raises USD20 Million in Series C Financing 12
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 13
Clearside Biomedical Raises US$8 Million In Venture Financing 14
Clearside Biomedical Raises Additional Funds In Series A Financing 16
Partnerships 17
Santen Expands Research Agreement with Clearside Biomedical 17
Santen Enters Into Research Agreement With Clearside Biomedical 18
Licensing Agreements 19
Spark Therapeutics Enters into Option Agreement with Clearside Biomedical to License Gene Therapy 19
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 20
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 21
Equity Offering 22
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 22
Clearside Biomedical Prices IPO for USD50.4 Million 23
Clearside BioMedical Inc - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Clearside BioMedical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Clearside BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Clearside Biomedical Raises USD0.3 Million in Venture Financing 12
Clearside Biomedical Raises USD20 Million in Series C Financing 12
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 13
Clearside Biomedical Raises US$8 Million In Venture Financing 14
Clearside Biomedical Raises Additional Funds In Series A Financing 16
Santen Expands Research Agreement with Clearside Biomedical 17
Santen Enters Into Research Agreement With Clearside Biomedical 18
Spark Therapeutics Enters into Option Agreement with Clearside Biomedical to License Gene Therapy 19
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 20
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 21
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 22
Clearside Biomedical Prices IPO for USD50.4 Million 23
Clearside BioMedical Inc, Key Competitors 25
Clearside BioMedical Inc, Key Employees 26

List of Figures
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Clearside BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838